The German firm supplies about three-quarters of the bone cement needed in the NHS. The product is used in more than 1,000 operations a week, mostly in knee replacements, but also in some hip and shoulder replacements.
而在FGFR3抑制剂赛道，针对泛FGFR抑制剂的安全性短板，行业开始向高选择性靶向方向升级，本土药企更是在其中占据了一席之地。
。快连下载安装对此有专业解读
// It is a promise that, when resolves, indicates that
其天使轮投资方为红杉种子基金、深圳高新投及璞跃中国。Pre-A轮融资由博远资本领投，蓝郡资本跟投。资金主要用于核心技术的迭代研发、产能提升、团队扩充以及市场拓展等。
Последние новости